SCHEMBL8728320

SCHEMBL8728320

COc1ccc(C(=O)c2ccc(O)c([N+](=O)[O-])c2)cc1OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.63
TSHR P16473 2/20 0.63
CYP1A2 P05177 1/20 0.63
CYP2C9 P11712 1/20 0.63
CYP2C19 P33261 1/20 0.63
SLC22A6 Q4U2R8 1/20 0.59
SLC22A8 Q8TCC7 1/20 0.59
ALDH1A1 P00352 6/20 0.56
MAPT P10636 5/20 0.56
GAA P10253 2/20 0.55
DPP4 P27487 1/20 0.53
PREP P48147 1/20 0.53
DPP9 Q86TI2 1/20 0.53
LMNA P02545 2/20 0.52
HPGD P15428 2/20 0.52
RAF1 P04049 1/20 0.52
MAPK1 P28482 1/20 0.52
GFER P55789 1/20 0.52
PAX8 Q06710 1/20 0.52
TUBB4A P04350 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4818648 0.90 CYP3A4 (0.69) CYP3A4TSHRCYP1A2CYP2C9CYP2C19
SCHEMBL7369400 0.87 TTR (0.67) CYP3A4TSHRCYP1A2CYP2C9CYP2C19
SCHEMBL4825935 0.87 CYP3A4 (0.69) CYP3A4TSHRCYP1A2CYP2C9CYP2C19
SCHEMBL30639036 0.87 CYP3A4 (0.69) CYP3A4TSHRCYP1A2CYP2C9CYP2C19
SCHEMBL3824914 0.85 ALDH1A1 (0.63) CYP3A4TSHRCYP1A2CYP2C9CYP2C19
SCHEMBL7103159 0.84 VCAM1 (0.65) TSHRCYP2C19ALDH1A1MAPTLMNA
SCHEMBL7369813 0.81 SLC22A6 (0.89) CYP3A4TSHRCYP1A2CYP2C9CYP2C19
SCHEMBL8017650 0.81 LMNA (0.61) CYP3A4TSHRCYP1A2CYP2C9CYP2C19
SCHEMBL5073540 0.81 CYP1A2 (0.69) CYP3A4TSHRCYP1A2CYP2C9CYP2C19
SCHEMBL4818707 0.80 TUBB4A (0.62) CYP3A4TSHRCYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed